Global Human Growth Hormone (hGH) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Human Growth Hormone (hGH) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 192-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
Human Growth Hormone (hGH) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Growth Hormone (hGH) market is projected to reach US$ 5669.5 million in 2034, increasing from US$ 4455.2 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Growth Hormone Deficiency and Turner Syndrome are the major drivers for the industry.
For industry structure analysis, the Human Growth Hormone industry is very concentrated. These manufacturers ranging from large multinational corporations to small privately owned companies compete in this industry. The top five producers include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono and F. Hoffmann-La Roche, account for more than 80% of the revenue market. Regionally, North America is the biggest production value area of valves, also the leader in the whole Human Growth Hormone industry.
North America occupied 42% of the production market. It is followed by Europe and China, which respectively have around 27% and 16% of the global total industry. Other countries have a small amount of production. Geographically, North America was the largest consumption market in the world, which took about 44.60% of the global consumption volume.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Growth Hormone (hGH) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck&Co.,Inc
Eli Lilly and Company
Genentech,Inc.
Novo Nordisk
Sandoz International GmbH
Ferring Holding SA
Ipsen
Segment by Type
Powder
Solvent
Growth Hormone Deficiency
Turner Syndrome
Idiopathic Short Stature
Prader-Willi Syndrome
Small for Gestational Age
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Human Growth Hormone (hGH) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Growth Hormone (hGH), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Growth Hormone (hGH) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Human Growth Hormone (hGH) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Growth Hormone (hGH) introduction, etc. Human Growth Hormone (hGH) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Human Growth Hormone (hGH) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Human Growth Hormone (hGH) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Growth Hormone (hGH) market is projected to reach US$ 5669.5 million in 2034, increasing from US$ 4455.2 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Growth Hormone Deficiency and Turner Syndrome are the major drivers for the industry.
For industry structure analysis, the Human Growth Hormone industry is very concentrated. These manufacturers ranging from large multinational corporations to small privately owned companies compete in this industry. The top five producers include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono and F. Hoffmann-La Roche, account for more than 80% of the revenue market. Regionally, North America is the biggest production value area of valves, also the leader in the whole Human Growth Hormone industry.
North America occupied 42% of the production market. It is followed by Europe and China, which respectively have around 27% and 16% of the global total industry. Other countries have a small amount of production. Geographically, North America was the largest consumption market in the world, which took about 44.60% of the global consumption volume.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Growth Hormone (hGH) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck&Co.,Inc
Eli Lilly and Company
Genentech,Inc.
Novo Nordisk
Sandoz International GmbH
Ferring Holding SA
Ipsen
Segment by Type
Powder
Solvent
Segment by Application
Growth Hormone Deficiency
Turner Syndrome
Idiopathic Short Stature
Prader-Willi Syndrome
Small for Gestational Age
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Human Growth Hormone (hGH) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Growth Hormone (hGH), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Growth Hormone (hGH) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Human Growth Hormone (hGH) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Growth Hormone (hGH) introduction, etc. Human Growth Hormone (hGH) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Human Growth Hormone (hGH) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.